Alvelestat for AATD meets primary endpoints in phase 2 trial Presented ByProf. Robert Stockley, University Hospital Birmingham, UK TrialPhase 2, ASTRAEUS ConferenceATS 2023 TypeNews article 12 June 2023 16:08